Search Results - Julien Edeline

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma by Victoria Foy, Mairéad G. McNamara, Juan W. Valle, Angela Lamarca, Julien Edeline, Richard A. Hubner

    Published in Current Oncology (2023-09-01)
    Get full text
    Article


  2. 2

    Factors associated with cancer treatment resumption after ICU stay in patients with solid tumors by Soraya Benguerfi, Ondine Messéant, Benoit Painvin, Christophe Camus, Adel Maamar, Arnaud Gacouin, Charles Ricordel, Jean Reignier, Emmanuel Canet, Julien Edeline, Jean-Marc Tadié

    Published in Annals of Intensive Care (2024-08-01)
    Get full text
    Article


  3. 3

    TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p by Corentin Louis, Tanguy Ferlier, Raffaële Leroux, Raphaël Pineau, Matthis Desoteux, Panagiotis Papoutsoglou, Delphine Leclerc, Gaëlle Angenard, Javier Vaquero, Rocio I.R. Macias, Julien Edeline, Cédric Coulouarn

    Published in JHEP Reports (2023-12-01)
    Get full text
    Article


  4. 4

    Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas by Camille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, Boris Campillo-Gimenez, Olivier Farges, David Tougeron, Isabelle Baumgaertner, Ahmet Ayav, Luc Beuzit, Marc Pracht, Astrid Lièvre, Samuel Le Sourd, Karim Boudjema, Yan Rolland, Etienne Garin, Eveline Boucher, Julien Edeline

    Published in Current Oncology (2021-11-01)
    Get full text
    Article


  5. 5

    First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort by Nicolas Adamus, Julien Edeline, Julie Henriques, Nadim Fares, Thierry Lecomte, Anthony Turpin, Dewi Vernerey, Mathilde Vincens, Brice Chanez, David Tougeron, Christophe Tournigand, Eric Assenat, Matthieu Delaye, Sylvain Manfredi, Olivier Bouché, Nicolas Williet, Angelique Vienot, Lorraine Blaise, Léo Mas, Cindy Neuzillet, Alice Boilève, Gaël S. Roth

    Published in JHEP Reports (2025-02-01)
    Get full text
    Article


  6. 6

    Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi) by Marine Valery, Julien Edeline, Julie Henriques, Leony Antoun, Heloise Bourien, Antoine Lebeaud, Nadim Fares, Christophe Tournigand, Thierry Lecomte, David Tougeron, Vincent Hautefeuille, Angelique Vienot, Nicolas Williet, Jean-Baptiste Bachet, David Malka, Cristina Smolenschi, Antoine Hollebecque, Jane-Rose Paccard, Maxime Frélaut, Pascal Hammel, Anthony Turpin, Alice Boileve

    Published in Therapeutic Advances in Medical Oncology (2025-09-01)
    Get full text
    Article


  7. 7

    Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies by Richard S. Finn, Kangsheng Gu, Xi Chen, Philippe Merle, Kyung-Hun Lee, Mohamed Bouattour, Peiguo Cao, Wei Wang, Ann-Lii Cheng, Liangjun Zhu, Ho Yeong Lim, Masatoshi Kudo, Yueyin Pan, Ting-Tsung Chang, Julien Edeline, Wei Li, Ping Yang, Chen Li, Jianfeng Li, Abby B. Siegel, Shukui Qin

    Published in JHEP Reports (2025-06-01)
    Get full text
    Article


  8. 8

    Correction to “New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe” [The Lancet Regional Health – Europe, volume 50, Ma... by Lorenza Rimassa, Angela Lamarca, Grainne M. O'Kane, Julien Edeline, Mairéad G. McNamara, Arndt Vogel, Matteo Fassan, Alejandro Forner, Timothy Kendall, Jorge Adeva, Andrea Casadei-Gardini, Lorenzo Fornaro, Antoine Hollebecque, Maeve A. Lowery, Teresa Macarulla, David Malka, Elene Mariamidze, Monica Niger, Anu Ustav, John Bridgewater, Rocio I.R. Macias, Chiara Braconi

    Published in The Lancet Regional Health. Europe (2025-06-01)
    Get full text
    Article


  9. 9

    TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial by Cyrille Féray, Loic Campion, Philippe Mathurin, Isabelle Archambreaud, Xavier Mirabel, Jean Pierre Bronowicki, Emmanuel Rio, Christophe Perret, Laurent Mineur, Frédéric Oberti, Yann Touchefeu, Jérôme Gournay, Hélène Regnault, Julien Edeline, Agnès Rode, Patrick Hillion, Jean Frédéric Blanc, Eric Nguyen Khac, Daniel Azoulay, Alain Luciani, Athena Galetto Preglisasco, Elodie Faurel-Paul, Hélène Auble, Françoise Mornex, Philippe Merle

    Published in JHEP Reports (2023-04-01)
    Get full text
    Article


  10. 10

    Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial by Zhenggang Ren, Michel Ducreux, Ghassan K. Abou-Alfa, Philippe Merle, Weijia Fang, Julien Edeline, Zhiwei Li, Lihua Wu, Eric Assenat, Sheng Hu, Lorenza Rimassa, Tao Zhang, Jean-Frédéric Blanc, Hongming Pan, Paul Ross, Chia-Jui Yen, Albert Tran, Guoliang Shao, Mohamed Bouattour, Yajin Chen, Tim Meyer, Jinlin Hou, David Tougeron, Yuxian Bai, Ming-Mo Hou, Zhiqiang Meng, John Wu, Vincent Li, Sandra Chica-Duque, Ann-Lii Cheng

    Published in Liver Cancer (2022-10-01)
    Get full text
    Article


Search Tools: